Last reviewed · How we verify

NCT04327817: MUST

Multifidus PET Scan Study

Completed Phase 4 Last updated 21 November 2025
What this trial tests

Phase 4 trial testing Multifidus stimulator in Low Back Pain in 20 participants. Completed in 17 March 2025.

Timeline
19 August 2021
Primary endpoint
17 March 2025
17 March 2025

Quick facts

Lead sponsorBarts & The London NHS Trust
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date19 August 2021
Primary completion17 March 2025
Estimated completion17 March 2025
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Barts & The London NHS Trust — full company profile →

Who can join

Adults 22 to 75, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study involves investigating phenotypic changes (ie metabolic activity in brain pain matrix areas, metabolic activity and textural analysis of multifidus muscle) following multifidus stimulation and establishing relationship with the change in pain, functionality and quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. British Pain Society, Annual Scientific Meeting
    · 2024

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Barts & The London NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04327817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing